Stay updated with breaking news from Dimitri dimitriou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines ImmuPharma CEO steps down investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
London Shares End Month With Mixed Results morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Investegate |Immupharma PLC Announcements | Immupharma PLC: Board Appointment investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Des avancées cliniques en vue pour ImmuPharma sudinfo.be - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sudinfo.be Daily Mail and Mail on Sunday newspapers.
About ImmuPharma PLC ImmuPharma PLC (LSE AIM: IMM - Euronext Growth: ALIMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company s portfolio includes novel peptide therapeutics for autoimmune diseases, metabolic diseases, anti-infectives and cancer. The lead program, Lupuzor™, is a first-in class autophagy immunomodulator which is in Phase 3 for the treatment of lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action. ImmuPharma and Avion Pharmaceuticals signed on 28 November 2019, an exclusive licence and development agreement and trademark agreement for Lupuzor™ to fund a new international Phase 3 trial for Lupuzor™ and commercialise in the US. ....